financetom
Business
financetom
/
Business
/
Pilates chain Solidcore explores sale, sources say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pilates chain Solidcore explores sale, sources say
May 9, 2024 11:23 AM

NEW YORK, May 9 (Reuters) - Pilates studio operator

Solidcore is exploring options including a potential sale that

could value the fitness chain at more than $750 million,

including debt, people familiar with the matter said on

Thursday.

The company, known for its challenging 50-minute workout

classes on its "sweatlana" reformers, is working with investment

banks North Point and Piper Sandler ( PIPR ) on its sale process, the

sources said, requesting anonymity as the discussions are

confidential.

For 2024, the company expects to generate about $50 million

of earnings before interest, taxes, depreciation and

amortization and roughly $150 million of revenue, the sources

said.

Founder Anne Mahlum launched Solidcore in 2013 and sold her

stake in the fitness chain last year. The company is currently

owned by investors VMG Partners, Peterson Partners and Kohlberg

& Company.

Solidcore, Piper Sandler ( PIPR ), VMG, Kohlberg and Peterson

declined to comment. North Point did not immediately respond to

requests for comment.

Washington, D.C.- based Solidcore has over 100 locations in

25 states, and plans to expand internationally to have 250

studios globally by 2028, it said last year.

The fitness and wellness industry has traditionally been

attractive to private equity investors, due to the steady and

predictable cash flows businesses in the sector generate.

Gym chains and workout studios globally have witnessed a

rebound in their fortunes since the COVID-19 pandemic subsided,

as more consumers resumed in-person workout sessions.

Another fitness chain Barry's Bootcamp is also exploring a

sale, Bloomberg reported last month.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Latin Metals Reports La Flora Assay Results
Latin Metals Reports La Flora Assay Results
Feb 4, 2025
11:08 AM EST, 02/04/2025 (MT Newswires) -- Latin Metals ( LMSQF ) on Tuesday reported recent exploration results at La Flora project, within the Cerro Bayo property in Argentina. At La Flora, samples were collected from two outcropping structures where visible gold was observed. Assay results from these samples returned values of up to 82 g/t gold and 1,239 g/t...
Update: Aya Gold & Silver Expands Boumadine Project in Morocco
Update: Aya Gold & Silver Expands Boumadine Project in Morocco
Feb 4, 2025
11:07 AM EST, 02/04/2025 (MT Newswires) -- (Adds analyst comment and updates shares.) Aya Gold & Silver ( AYASF ) on Tuesday said it expanded its Boumadine project in Morocco by 28% after securing the right to four additional mining licenses. The four licenses totaled 59.9 square kilometers, increasing the property's size to more than 272 square kilometers. The company...
BlackBerry Completes Sale of Cylance Assets to Arctic Wolf
BlackBerry Completes Sale of Cylance Assets to Arctic Wolf
Feb 4, 2025
11:05 AM EST, 02/04/2025 (MT Newswires) -- BlackBerry (BB) and Arctic Wolf said that Arctic Wolf has completed the acquisition of BlackBerry's Cylance endpoint security assets. Under the terms of the transaction, announced in December, BlackBerry will receive $160 million in cash and about 5.5 million Arctic Wolf shares. Shares of BlackBerry were up 4.5% in recent trading. Price: 4.55,...
What's Going On With Aclarion Stock Tuesday?
What's Going On With Aclarion Stock Tuesday?
Feb 4, 2025
Aclarion, Inc. ( ACON ) stock is trading higher on Tuesday after the company announced it secured funding for its CLARITY trial of its diagnostic tool, Nociscan. What To Know: The company has raised approximately $20 million in gross proceeds since the start of 2025, which will fully fund the clinical trial. The trial aims to test Nociscan's ability to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved